Results 51 to 60 of about 2,643,317 (205)
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV [PDF]
, 2014 The impact of imatinib dose on response rates and survival in older patients with chronic myeloid leukemia in chronic phase has not been studied well. We analyzed data from the German CML-Study IV, a randomized five-arm treatment optimization study in ...Annette Schreiber, Lothar Müller, Hofmann, Wolf-Karsten, Hanfstein, Benjamin, Krause, Stefan W., Benjamin Hanfstein, Müller, Martin C, Michael Lauseker, Kremers, Stephan, Bernd Hertenstein, Hasford, Joerg, Rüdiger Hehlmann, Joerg Hasford, Wolf-Karsten Hofmann, Schlag, Rudolf, Hehlmann, Rüdiger, null null, Stephan Kremers, Müller, Lothar, Mathias Hänel, Hänel, Mathias, Nadine Pletsch, Martin C. Müller, Gabriela M. Baerlocher, Dominik Heim, Saußele, Susanne, Krause, Stefan W, Hartmut Link, Pfirrman, Markus, Baerlocher, Gabriela M., Stefan W. Krause, Pfirrmann, Markus, Wernli, Martin, Martin Wernli, Markus Pfirrmann, Hertenstein, Bernd, Link, Hartmut, Rudolf Schlag, Hermann Einsele, Pletsch, Nadine, Schreiber, Annette, Elisabeth Lange, Müller, Martin C., Lange, Elisabeth, Hochhaus, Andreas, Lida Kalmanti, Lauseker, Michael, Kalmanti, Lida, Ulrike Proetel, Heim, Dominik, Susanne Saußele, Proetel, Ulrike, Einsele, Hermann, Andreas Hochhaus, Urmersbach, A., Kloke, O., Weischer, H., Thiel, E., Müller, L. L., Hoyer, A., Goebeler, M. E., Le Coutre, P., Illerhaus, G., Lenk, G., Henzel, A., Gröschel, W., Steinmetz, H. T., Hahn, L., Flaßhove, M., Schadeck-Gressel, C., Lunscken, C., Sandritter, B., Burchert, A., Hesse, A., Schlimok, G., Dölken, G., Schulz, L., Heim, D., Kingreen, D., Fischer, C., Hoeffkes, H. G., Heßling, J., Rudolph, R., Mittermüller, J., Weidinger, P., Käfer, G., Biaggi, C., Hochhaus, A., Zöller, T., Nusch, A., Prümmer, O., Lambertz, H., Greif, D., Neben, K., Köster, H., Janzen, V., Weiß, B., Wernli, M., Schlegel, F., Müller, F., Kolb, H. J., Moeller, R., Maintz, C., Engel, E., Wattad, M., Schanz, S., Stötzer, O., Clemens, M., Freier, W., Kemper, J., Burchardt, A., Günther, E., Hollburg, W., Hess, U., Snaga, A., Saußele, S., Hahn, M., Janssen, J., Koch, B., Völkl, S., Bentz, M., Ganser, A., Haferlach, C., Lamberti, C., Gregor, M., Reschke, D., Lutz, L., Forstbauer, H., Schmidt-Wolf, I., Spiekermann, K., Müller, L., Diekmann, C., Schenk, M., Jäger, E., Kremers, S., Hirt, C., Brandt, M., van der Linde, M., Beelen, D. W., Fritz, L., Müller, M., Rösel, S., Brettner, S., Sauer, M., Lämmle, B., Al-Batran, S. E., Koschmieder, Steffen, Sosada, M., Simon, M., Krause, S., Neubauer, A., Waller, C., Elsel, W., Eschenburg, H., Staib, P., Schäfer, E., Karbach, U., Sauerbruch, T., Strack, U., Bartholomäus, A., Bargetzi, M., Mahlmann, S., Seitz, K., Schmidt, B., Mergenthaler, H. G., Hensel, M., Kirchner, H. H., Neumann, F., Strotkötter, H., Morgner, A., Vaupel, H. A., Müller-Naendrup, C., Gnad, M., Mayer, J., Tajrobehkar, K., Kiani, A., Lindemann, A., Marth, T., Uppenkamp, M., Kempf, B., Langer, W., Büschel, G., Edinger, R., Schafhausen, P., German Chronic Myeloid Leukemia Study Group, Dencausse, Y., Kühnemund, A., Kleeberg, U., Dengler, J., Thum, P., Weidenhöfer, S., Denzlinger, C., Falge, C., Haatanen, T., Döhner, H., Lange, E., Rech, D., Braumann, D., Peest, D., Andreesen, R., Wagner, S., Trenschel, R., Reichert, P., Englisch, H. J., Kreuser, E. D., Schelenz, C., Hoffmann, R., Staiger, H. J., Kamp, T., Rothaug, W., Stauch, M., Martin, H., Groß, V., Fett, W., Matek, W., Waladkhani, A. R., Lange, C., Hertenstein, B., Hahn-Ast, C., Blau, I., Porowski, P., Baldus, M., Schmielau, J., Bokemeyer, C., Heinkele, P., Stier, S., Ratei, R., Wilhelm, S., Jürß, C., Rendenbach, B., Behringer, D., Paliege, R., Lollert, A., Mandel, T., Arnold, R., Ottmann, O. G., Severin, K., Fritsch, G., Müller, S., Schüler, F., Kleiß, M., Göttler, B., Rohlfing, S., Zirpel, I., Cerny, T., Ranft, K., Kujickova, J., Tichelli, A., Sieber, M., Lordick, F., Heit, W., Köchling, G., Just, M., Oldenkott, B., Bross-Bach, U., Schlag, R., Reichert, D., Laubenstein, H. P., Weiß, U., Raghavachar, A., Schleicher, J., Fuss, H., Reiber, T., Hehlmann, R., Frühauf, S., Trenn, G., Fischer, T., Kanz, L., Runde, V., Platz, D., Wandt, H., Schick, H. D., Möller-Faßbender, F., Moritz, T., Fetscher, S., Kneba, M., Dengler, R., Mück, R., Zácková, D., Schmitz, N., Wehmeier, A., Schmiegel, W., Krauter, J., Häcker, B., Springer, G., Heymanns, J., Stange-Budumlu, O., Schwerdtfeger, R., Vehling-Kaiser, U., Gatter, J., Brust, J., Baerlocher, G., Hofmann, W. K., Burmeister, T., Goldmann, B., Illmer, T., Baur, F. K., Herbst, R., Pihusch, R., Schuster, D., Eimermacher, H., Link, H., Fiechtner, H., Krause, S. W., Wendtner, C., Ritter, P. R., Wilhelm, M., Furkert, J., Berdel, W. E., La Rosée, P., Fischer von Weikersthal, L., Neuhaus, T., Baake, G., Teutsch, C., Schmidt, G., Schmidt, C. A., Notter, M., Bechtel, B., Frieling, T., Wejda, B., Janz, R., Fauser, A., Pralle, H., Hermann, T., Schmitz, S., Matzdorff, A., Menzel, J., Kemmerling, M., Beyer, J., Peyn, A., Schweiger, C., Griesshammer, M., Gassmann, W., Ludwig, F., Schlegelberger, B., Kaiser, U., Suna, H., Dürk, H. A., Ho, A. D., Wolf, H. H., Woska, E., Wätzig, K., Schmoll, H. J., Tobler, A., Valverde, M. L., Schmidt, E., Köhne, C. H., Schmier, M., Reeb, M., Trümper, L., Wuillemin, W., Hänel, M., Spohn, C., Planker, M., Haferlach, T., Verbeek, W., Westheider, J., Tischler, H. J., Mackensen, A., Schoch, R., Ihle, H., Lindemann, H. W., Theilmann, L., Koppele, A., Kaesberger, J., Koschuth, A., Zeller, C., Hiddemann, W., Stegelmann, F., Wolf, T., Schröder, M., Braun, B., Grimminger, W., Wehmeyer, J., Becker, M., Oppliger Leibundgut, E., Friess, D., Tessen, H. W., Gratwohl, A., Kalhori, N., Middeke, H., Hoelzer, P., Graeven, U., Hentrich, M., Doering, G., Serve, H., Scheidegger, C., Priebe-Richter, C., Mezger, J., Eckart, M., Henneke, F., Hüttmann, A., Scheid, C., Jacki, S. H., Pommerien, W., Neumann, S., Ludwig, W. D., Sperling, C., Hanfstein, B., Dahmen, E., Heil, G., Buß, E. C., Nerl, C., Semsek, D., März, W., Platzbecker, U., Nickelsen, M., Schubert, J., Aul, C., Linck, D., Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK), Römer, E., Depenbusch, R., Hieber, U., Weiß, J., Kullmer, J., Theobald, M., Geer, T., Kunzmann, V., Rummel, M. J., Pflüger, K. H., Ladda, E., Badrakhan, C. D., Ehninger, G., Schatz, M., Boewer, C., Korsten, S., Sievers, B., Ko, Y. D., Thomas, S., Hebart, H., de Wit, M., Majunke, P. J., Schnittger, S., Pfreundschuh, M., Schmidt, P., Kämpfe, D., Wacker, D., Hitz, H., Hartmann, F., Hoffmann, D., Novotny, J., Herr, W., Stahlhut, K., Neise, M., Hoffknecht, M. M., Dietzfelbinger, H., Gmür, J., Petersen, V., Groschek, M., Munzinger, H., Giagounidis, A., Hossfeld, D., Freunek, G., Hemeier, M., Heidemann, E., Schlenska-Lange, A., Derwahl, K. M., Wacker, A., Hansen, R., Demandt, M., Binder, C., Klein, O., Plöger, C., Josten, K. M., Grote-Metke, A., Pollmeier, G., Henesser, D. +467 morecore +2 more sourcesA Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia [PDF]
Journal of Korean Medical Science, 2006 Pleural effusion in chronic myeloid leukemia (CML) is poorly understood and rarely reported in the literature. When the pleural effusion is caused by leukemic pleural infiltration, the differential white blood cell count of the effusion is identical to that of the peripheral blood, and the fluid cytology reveals leukemic blasts.Kim, Hyun Woo, Lee, Sung Sook, Ryu, Min-Hee, Lee, Jae Lyun, Chang, Heung Moon, Kim, Tae Won, Chi, Hyun-Sook, Kim, Woo Kun, Lee, Jung Shin, Kang, Yoon-Koo +9 moreopenaire +2 more sourcesChromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics (GFCH)
American Journal of Hematology, EarlyView.ABSTRACT
Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the Francophone Group of Hematological Cytogenetics (Groupe Francophone de Cytogénétique Hématologique, GFCH) conducted a ...Florence Nguyen‐Khac, Audrey Bidet, Elise Chapiro, Nathalie Douet‐Guilbert, Jean‐Baptiste Gaillard, Nada Assaf, Nathalie Auger, Hend Chaker, Jasmine Chauzeix, Inge Govaerts, Hippolyte Guérineau, Christine Lefebvre, Pauline Roynard, Hélène Guermouche, Lucienne Michaux, Marie‐Bérengère Troadec, Lauren Véronèse +16 morewiley +1 more sourceBone marrow‐like viscosity affects imatinib resistance in chronic myeloid leukemia
Biotechnology Progress, EarlyView.Physical cues such as microenvironmental viscosity have been recognized as important regulators in controlling cell functions. However, even though the bone marrow (BM) is a viscous tissue in which cells respond mechanically to both the matrix stiffness and the viscosity of surrounding fluid, the impact of microenvironmental viscosity on imatinib (IM ...Tianjiao Zeng, Huajian Chen, Man Wang, Toru Yoshitomi, Naoki Kawazoe, Yingnan Yang, Guoping Chen +6 morewiley +1 more sourceCSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile
Leukemia Research Reports, 2022 Chronic myelomonocytic leukemia (CMML) is a clonal myeloid neoplasm characterized by sustained monocytosis and mutations in TET2, ASXL1, SRSF2, SETBP1, NRAS, and KRAS. We describe a rare case of CSF3R T618I mutated CMML that has a proliferative phenotype,Adelaide Kwon, Ibrahim Ibrahim, Tri Le, Jesse Manuel Jaso, Olga Weinberg, Franklin Fuda, Weina Chen +6 moredoaj +1 more sourceA case series of necrotizing periodontal diseases in hospitalized patients: What hasn't been said yet?
Clinical Advances in Periodontics, EarlyView.Abstract Background
Necrotizing periodontal diseases (NPDs) are uncommon and severe inflammatory conditions characterized by tissue necrosis, painful ulceration, and rapid clinical progression, frequently associated with systemic immunosuppression. Limited data exist regarding their clinical presentation and management in hospital settings.Osmaria Letthycia Carvalho Leal, Fernanda Bortolotto, Mariana Cristina Manoel, Gabriela Silveira de Araújo, Ana Carolina Fragoso Motta, Leandro Dorigan de Macedo, Lara Maria Alencar Ramos Innocentini, Joab Cabral Ramos, Isabel Schausltz Pereira Faustino +8 morewiley +1 more sourceOmacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells [PDF]
, 2011 Chronic myeloid leukaemia (CML) is maintained by a rare population of tyrosine kinase inhibitor (TKI)-insensitive malignant stem cells. Our long-term aim is to find a BcrAbl-independent drug that can be combined with a TKI to improve overall disease ...E K Allan, Holyoake, T.L., Jorgensen, H.G., A R Craig, T L Holyoake, Allan, E.K., Craig, A.R., H G Jørgensen +7 morecore +1 more source